Image: stockmedia.cc [CC BY 3.0], via Freeimageslive.co.uk
Medicines regulator needs to become “investment centre” to achieve UK life sciences superpower ambition
Investment is needed for the UK’s medicines regulator to become an “enabler” of innovation, according to a leading figure in the life sciences industry.
Stuart Carroll, director of market access and policy affairs at pharmaceutical company Moderna, said the Medicines and Healthcare products Regulatory Agency should become an “investment centre” if the UK government wanted to achieve its life sciences superpower ambition.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.